Menu
Recruiting NCT07281313

Aphasia Physical EXercise Study: Randomized Trial

No phase Interventional Aphasia, Acquired Aphasia Aphasia, Fluent Aphasia, Non-fluent

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: High-intensity physical exercise, Low-intensity physical exercise.
Who it may be relevant to
Registry conditions: Aphasia, Acquired, Aphasia, Aphasia, Fluent, Aphasia, Non-fluent. Basic parameters: 18 years — 80 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
United States
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

High-intensity Exercise in Stroke Recovery: Randomized Trial

Overview

The goal of this clinical trial is to evaluate the effects of a high-intensity exercise program on recovery in individuals with post-stroke aphasia. The high-intensity exercise program has been specifically designed for individuals with post-stroke aphasia and includes an interval training full-body workout, which can increase cardiovascular fitness, improve muscle strength and motor performance, and maximize cognitive and language gains. The main question this study aims to answer is: • Does participation in a high-intensity exercise program lead to changes in physical health, language, cognitive, motor recovery, psychological and/or psychosocial domains? Participants will be randomly assigned to either a high-intensity exercise program (target intervention) or a low-intensity exercise program (control intervention) delivered over 12-weeks in a group setting. Outcome measures will be collected once immediately after the intervention period and once during the following 12-week maintenance period to capture short- and long-term effects of the exercise program.

Interventions

  • Behavioral High-intensity physical exercise
    We have developed a new exercise program specifically designed for individuals with post-stroke aphasia, Aphasia Physical EXercise (APEX), to provide a safe, stroke- and aphasia-friendly physical exercise intervention to achieve optimal physical fitness and cognitive/language gains. This intervention, based on published research and clinical practice recommendations, is a high-intensity interval training full-body workout optimized to accommodate the range of motor abilities and general decondit
  • Behavioral Low-intensity physical exercise
    As an active control intervention, a low-intensity non-aerobic exercise program was selected that mirrors more closely the standard-of-care physical therapy currently provided to stroke patients. This control intervention will offer the same level of participant involvement and type of interaction, but without the intensity element, i.e., it will not incorporate the cardiovascular and the strengthening components.

Primary outcome measures

  • Change on the Western Aphasia Battery (WAB) - Aphasia Quotient [Time frame: (T1) Baseline: at the start of the study; (T2) Pre-treatment: 1 week prior to the start of the intervention; (T3) Post-treatment: the week immediately following the intervention; (T4) Follow-up: 3 months after the conclusion of the intervention.]
Secondary outcome measures (11)
  • Change on the WAB subtest scores [Time frame: (T1) Baseline: at the start of the study; (T2) Pre-treatment: 1 week prior to the start of the intervention; (T3) Post-treatment: the week immediately following the intervention; (T4) Follow-up: 3 months after the conclusion of the intervention.]
  • Change on the Curtiss-Yamada Comprehensive Language Evaluation - Revised (CYCLE-R) [Time frame: (T1) Baseline: at the start of the study; (T2) Pre-treatment: 1 week prior to the start of the intervention; (T3) Post-treatment: the week immediately following the intervention; (T4) Follow-up: 3 months after the conclusion of the intervention.]
  • Changes on Category and Letter Verbal Fluency tasks [Time frame: (T1) Baseline: at the start of the study; (T2) Pre-treatment: 1 week prior to the start of the intervention; (T3) Post-treatment: the week immediately following the intervention; (T4) Follow-up: 3 months after the conclusion of the intervention.]
  • Change on the Philadelphia Naming Test (PNT) [Time frame: (T1) Baseline: at the start of the study; (T2) Pre-treatment: 1 week prior to the start of the intervention; (T3) Post-treatment: the week immediately following the intervention; (T4) Follow-up: 3 months after the conclusion of the intervention.]
  • Changes on the California Cognitive Assessment Battery (CCAB) [Time frame: (T1) Baseline: at the start of the study; (T2) Pre-treatment: 1 week prior to the start of the intervention; (T3) Post-treatment: the week immediately following the intervention; (T4) Follow-up: 3 months after the conclusion of the intervention.]
  • Changes in Maximal Aerobic Capacity [Time frame: (T1) Baseline: at the start of the study; (T2) Pre-treatment: 1 week prior to the start of the intervention; (T3) Post-treatment: the week immediately following the intervention.]
  • Change on the 2-minute Step Test [Time frame: (T1) Baseline: at the start of the study; (T2) Pre-treatment: 1 week prior to the start of the intervention; (T3) Post-treatment: the week immediately following the intervention; (T4) Follow-up: 3 months after the conclusion of the intervention.]
  • Change on the 30-second chair stands [Time frame: (T1) Baseline: at the start of the study; (T2) Pre-treatment: 1 week prior to the start of the intervention; (T3) Post-treatment: the week immediately following the intervention; (T4) Follow-up: 3 months after the conclusion of the intervention.]
  • Change on the Timed Up-and-Go Test [Time frame: (T1) Baseline: at the start of the study; (T2) Pre-treatment: 1 week prior to the start of the intervention; (T3) Post-treatment: the week immediately following the intervention; (T4) Follow-up: 3 months after the conclusion of the intervention.]
  • Change on the Functional Reach Test [Time frame: (T1) Baseline: at the start of the study; (T2) Pre-treatment: 1 week prior to the start of the intervention; (T3) Post-treatment: the week immediately following the intervention; (T4) Follow-up: 3 months after the conclusion of the intervention.]
  • Change in Gait Speed [Time frame: (T1) Baseline: at the start of the study; (T2) Pre-treatment: 1 week prior to the start of the intervention; (T3) Post-treatment: the week immediately following the intervention; (T4) Follow-up: 3 months after the conclusion of the intervention.]

Eligibility criteria

Inclusion criteria

  • Aphasia following ischemic or hemorrhagic stroke
  • Aphasia as determined by a standardized language test (Western Aphasia Battery Aphasia Quotient < 93.8 at study intake)
  • At least 6 months from the last stroke
  • Proficient in English before the stroke
  • At least 8 years of education
  • Between the ages of 18 and 80
  • Independent with ambulation without a device (single-point cane accepted)
  • Medically stable with no contraindications to participate in regular physical exercise as determined by the patients' own primary care provider or other treating provider.

Exclusion criteria

  • Prior history of dementia, neurologic illness (other than stroke), or recent (last 3 years) substance abuse
  • Significant visual or hearing disabilities (e.g., neglect, uncorrected visual or hearing loss) that interfere with testing
  • Self-report uncontrolled cardiorespiratory and/or metabolic disorders incompatible with exercise

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Allocation
Randomized
Model
Parallel assignment
Masking
Single blind
Primary purpose
Treatment

Study locations

United States · 4 centers
  • University of California, Berkeley — Berkeley
  • California State University, East Bay — Hayward
  • University of San Francisco — San Francisco
  • University of California, San Francisco — San Francisco

Identifiers

NCT: NCT07281313 · 20243771 · R01DC022663

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗